Suchergebnisse - "Sabljic, Anica"

PubPharm (20)

1

Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia

enthalten in: Leukemia & lymphoma | 2024

von Krecak, I. | Lekovic, D. | Grohovac, D. | +9

2

Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis

enthalten in: Life (Basel, Switzerland) | 2024

von Lucijanic, M. | Krecak, I. | Soric, E. | +8

3

Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk

enthalten in: Scandinavian journal of clinical and laboratory investigation | 2024

von Lucijanic, M. | Krecak, I. | Soric, E. | +9

4

Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab

enthalten in: Annals of hematology | 2024

von Lucijanic, M. | Sabljic, A. | Vlasac Glasnovic, J. | +3

5

Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes

enthalten in: Journal of thrombosis and thrombolysis | 2024

von Lucijanic, M. | Krecak, I. | Busic, I. | +9

6

Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms

enthalten in: Thrombosis research | 2023

von Krečak, I. | Grohovac, D. | Vučenović Bašić, N. | +9

7

Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time

enthalten in: Annals of hematology | 2023

von Lucijanic, M. | Veic, P. | Aric, I. | +7

8

Understanding and modifying thrombotic risk in patients with myeloproliferative neoplasms

enthalten in: Journal of cardiology | 2023

von Krecak, I. | Sabljic, A. | Lucijanic, M.

CommentOn: J Cardiol. 2023 Mar;81(3):260-267. - PMID 36384716

9

Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis

enthalten in: Biochemia medica | 2023

von Lucijanic, M. | Krecak, I. | Soric, E. | +7

10

Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time

enthalten in: Annals of hematology | 2023

von Lucijanic, M. | Veic, P. | Aric, I. | +7